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Rituximab and i.v. immunoglobulin 
for desensitization  
during renal transplantation
Highly HLA system-sensitized transplantation candidates 
often have long waiting times and significantly fewer chances 
to receive kidney transplants. A new open-label study explores 
the use of intravenous (i.v.) immunoglobulin and rituximab to 
improve both of these parameters in patients awaiting a kidney 
transplant. The study included patients who were HLA sensi-
tized, with mean panel-reactive antibody (PRA) levels of 77% ± 
19%, or who had donor-specific antibodies and were on a wait-
ing list for a kidney transplant from a deceased or living donor. 
They were given human polyclonal i.v. immunoglobulin, the first 
dose upon enrollment and the second dose 30 days later. Rituxi-
mab was also given twice, one gram 7 days after enrollment and 
a second gram 22 days after enrollment. At the time of trans-
plantation, patients were given a dose of alemtuzumab as induc-
tion therapy. Subsequently, prednisone, mycophenolate mofetil, 
and tacrolimus were administered as maintenance therapies for 
immunosuppression. Of the 20 patients, 16 underwent a suc-
cessful transplantation. PRA levels were significantly reduced 
after treatment when i.v. immunoglobulin and rituximab was 
given (Figure). Patient and allograft survival rates 12 months 
later among the 16 participants receiving a transplant were 100% 
and 94%, respectively. Acute rejection episodes occurred in 50% 
of patients who received transplants; one-third of these episodes 
were C4d+ antibody-mediated rejections. Most rejection epi-
sodes occurred within the first month after transplantation and 
were reversible with therapy. With moderate lengths of follow-
up (a mean of 22 months), no episodes of progressive multifocal 
leukoencephalopathy, viral infections, or infusion-related side 
effects occurred.
Negative cross-matches and receipts of kidneys in three-
quarters of this group is a remarkable outcome. Further, the 
regimen of i.v. immunoglobulin and rituximab appeared to be 
well tolerated. Future work needs to focus on how to ensure the 
best possible allograft and patient survival in these high-risk 
patients once they have received their kidneys. (N Engl J Med 
2008; 359: 242–251)
Lynda Szczech
Developmental plasticity  
of the ureteric bud
Branching morphogenesis of epithelia is common in mammalian 
organogenesis, such as in the development of the lung airways, milk 
ducts of the mammary glands, pancreatic ducts, and renal collecting 
ducts, among others. In general, these systems develop by dipodial 
branching, in which the ends of existing branches bifurcate and 
separate from one another as the tubule elongates. One unanswered 
question about branching morphogenesis is whether the ability to 
initiate new branches is confined only to certain cells in a branching 
epithelium—for example, those at the tip of an existing branch — 
or whether all parts of the epithelium can do it. The renal urinary 
collecting duct system arises from an initially unbranched epithe-
lium, the ureteric bud (a branch of the Wolffian duct), which invades 
the metanephric mesenchyme and branches within it to produce 
approximately 1600 branches during approximately 10−11 rounds 
of bifurcation. Detailed time-lapse observations of renal branching 
morphogenesis have shown that most branching events take place 
by bifurcation at the ends of existing branches. Cells in the terminal 
part of the branches (“tips”) are the main zones of cell proliferation 
and show patterns of gene expression that differ from those in the 
regions behind them (“stalks”). Tip-specific markers include Wnt11 
and Sox9, and stalk-specific markers include collagen XVIII, Wnt9b, 
and a glycoprotein that binds Dolichos biflorus agglutinin. The fact 
that most branching takes place in the tip zone, which shows gene 
expression different from that of the stalks, suggests that there may 
be a tip state of differentiation that makes cells capable of initiating 
branches. To determine whether cells that have differentiated into 
stalks retain the ability to make new tips, Sweeney et al. conducted a 
study in which they removed existing tips from stalks, verified that 
the stalks were free of tip cells, and assessed the ability of tip-free 
stalks to initiate new branches. They found stalks to be fully capable 
of regenerating tips that express typical tip markers, with these tips 
going on to form epithelial trees at high frequency (Figure). The tran-
sition from tip to stalk is therefore reversible, at least in early stages 
of development. This observation has important implications for 
models of pattern formation in branching morphogenesis and may 
also be important for tissue engineering and regenerative medicine. 
(Development 2008; 135: 2505−2510; doi:10.1242/dev.022145)
Juan Oliver
Panel-reactive antibody levels in the 20 study patients. IVIG, intravenous 
immunoglobulin.
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Regeneration of new branching epithelia from E11.5 ureteric bud stalks. 
New branching tree generated from an isolated E11.5 stalk surrounded 
by fresh mesenchyme, stained with anti-calbindin-D28K (a) and the stalk 
marker Dolichos biflorus agglutinin (b).
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Klotho causes cell-surface 
retention of TRPV5 channel  
via binding to galectin-1
A defect in the expression of the gene Klotho causes a com-
plex phenotype that resembles human aging, including short-
ened lifespan, infertility, muscle and skin atrophy, pulmonary 
emphysema, osteopenia, hyperphosphatemia, and vascular 
and soft tissue calcification. Conversely, overexpression of the 
encoded product, Klotho, extends lifespan. Klotho is a trans-
membrane protein mainly expressed in distal renal tubules, 
parathyroid glands, and choroid plexus epithelial cells. Klotho 
has a large extracellular domain that is found in urine, blood, 
and cerebrospinal fluid and elicits biological effects, suggest-
ing that it is a circulating hormone. Both full-length Klotho 
and its extracellular domain bind to multiple fibroblast growth 
factor (FGF) receptors and, by increasing their affinity for 
FGF23, are cofactors for its action. FGF23 is a hormone that 
decreases plasma phosphate by suppressing renal phosphate 
reabsorption, and decreases plasma 1,25(OH)2D by reducing 
its synthesis and increasing its metabolism. Klotho-deficient 
mice have hyperphospahtemia, hypercalcemia, and increased 
serum 1,25(OH)2D levels, abnormalities that are also found 
in FGF23-null mice. It was recently reported that Klotho, a 
β-glucuronidase, hydrolyzes extracellular sugar residues of 
the epithelial Ca2+ channel TRPV5, entrapping the channel 
in the plasma membrane and rendering it active. TRPV5 is 
involved in renal Ca2+ handling, and mice lacking TRPV5 
have diminished renal Ca2+ reabsorption, hypercalciuria, and 
increased levels of vitamin D. Cha et al. now report that activa-
tion of plasma membrane resident TRPV5 channels by Klotho 
involves removal of terminal sialic acids from their glycan 
chains, thus exposing underlying disaccharide N-acetyllactos-
amine (LacNAc), a ligand for galectin-1. Binding of LacNAc to 
galectin-1 at the extracellular surface results in accumulation 
of functional TRPV5 on the plasma membrane (Figure). This 
action of Klotho represents a novel mechanism for regulation 
of the activity of cell-surface glycoproteins and likely contrib-
utes to the maintenance of calcium homeostasis by Klotho. 
(Proc Natl Acad Sci USA 2008; 105: 9805−9810; doi:10.1073/
pnas.0803223105)
Juan Oliver
Loss of podoplanin protein, 
proteinuria, and alterations  
in podocyte morphology
The permselectivity of the glomerular filtration barrier restricts pas-
sage of proteins into Bowman’s space. Loss of permselectivity leads 
to proteinuria, common in renal diseases. Although the mechanisms 
of glomerular filtration remain unclear, it is clear that the glomerular 
visceral epithelial cell, or podocyte, is an important component of 
the glomerular filtration barrier; damage to podocytes is frequently 
involved in the pathogenesis of glomerular diseases.
To investigate changes during the development of proteinuria, 
Koop et al. evaluated podocyte morphology and protein expres-
sion in spontaneously proteinuric, Dahl salt-sensitive (Dahl SS) rats. 
Dahl SS rats on a low-salt diet were compared with spontaneously 
hypertensive (SHR) rats at ages 2, 4, 6, 8, and 10 weeks. The authors 
measured blood pressure, urinary protein excretion, urinary albu-
min excretion, and podocyte morphology. In addition, the expres-
sion of 11 podocyte-related proteins was determined by analysis of 
protein and mRNA levels. In Dahl SS rats, proteinuria was detected 
at 5 weeks and increased thereafter. SHR rats did not develop pro-
teinuria. Dahl SS rats showed widespread foot process effacement 
at 10 weeks. At 8 or more weeks, expression and distribution of the 
podocyte proteins were similar between the two strains, except for 
the protein podoplanin. At 4 weeks, podoplanin began decreasing 
in the glomeruli of Dahl SS rats in a focal and segmental fashion. 
Podoplanin loss increased progressively and correlated with albu-
minuria. Double-labeling experiments revealed increased expres-
sion of the podocyte stress marker desmin in glomerular areas 
where podoplanin was lost. Dahl SS rats did not show podoplanin 
gene mutations or decreased mRNA expression. Thus, podocyte 
morphology and the expression and distribution of most podocyte-
specific proteins were normal in young Dahl SS rats, despite marked 
proteinuria. This study suggests that lowered podoplanin expression 
plays a role in the decrease of glomerular permselectivity. (Am J 
Pathol 2008; 173: 315−326; doi:10.2353/ajpath.2008.080063)
Detlef Schlöndorff
Removal of sialic acid involving Klotho causes cell-surface retention of 
TRPV5 channel via binding to galectin-1.
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Electron microscopy of podocytes in Dahl SS and SHR rats.
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